Effect of tympanic cavity evacuation and flushing on microbial isolates during total ear canal ablation with later bulla osteotomy in dogs

Journal of the American Veterinary Medical Association

Volumn 227, Issue 5, 2005, Pages 748-755

  Hettlich, Bianca F ^a   Boothe, Harry W ^a,c   Simpson, R Bruce ^a   DuBose, Kim A ^b   Boothe, Dawn M ^a,c   Carpenter, Mark ^c  

^a TEXAS A AND M UNIVERSITY   (United States)

^b Department of Small Animal Clinical Sciences   (United States)

^c AUBURN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIINFECTIVE AGENT; CEFALOTIN; CEFAZOLIN; CEFTIOFUR; CHLORAMPHENICOL; CLINDAMYCIN; COTRIMOXAZOLE; DOXYCYCLINE; ENROFLOXACIN; ERYTHROMYCIN; GENTAMICIN; IMIPENEM; TICARCILLIN;

ACCURACY; AEROBIC BACTERIUM; ANAEROBIC BACTERIUM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATE; DOG; EAR SURGERY; EARDRUM; EVALUATION; FEMALE; LATERAL BULLA OSTEOTOMY; LAVAGE; MALE; NONHUMAN; OSTEOTOMY; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; PROSPECTIVE STUDY; REOPERATION; TOTAL EAR CANAL ABLATION;

ANIMALS; ANTI-BACTERIAL AGENTS; COLONY COUNT, MICROBIAL; DOG DISEASES; DOGS; DRUG RESISTANCE, BACTERIAL; EAR CANAL; EAR, MIDDLE; FEMALE; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; MALE; MICROBIAL SENSITIVITY TESTS; OSTEOTOMY; OTITIS EXTERNA; OTITIS MEDIA; PROSPECTIVE STUDIES;

ANIMALIA; CANIS FAMILIARIS;

EID: 24644462315     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: 10.2460/javma.2005.227.748     Document Type: Article

References (25)

1. Smeak DS. Total ear canal ablation and lateral bulla osteotomy. In: Bojrab MJ, ed. Current techniques in small animal surgery. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 1998;102-109.
2. Fossum TW. Surgery of the ear. In: Fossum TW, ed. Small animal surgery. 2nd ed. St Louis: CV Mosby Co, 2002;229-253.
3. Krahwinkel DJ. External ear canal. In: Slatter D, ed. Textbook of small animal surgery. 3rd ed. Philadelphia: WB Saunders Co, 2003;1746-1756.
4. Beckman SL, Henry WB, Cechner P. Total ear canal ablation combining bulla osteotomy and curettage in dogs with chronic otitis externa and media. J Am Vet Med Assoc 1990;196:84-89.
5. Cole LK, Kwochka KW, Kowalski JJ, et al. Microbial flora and antimicrobial susceptibility patterns of isolated pathogens from the horizontal ear canal and middle ear in dogs with otitis media. J Am Vet Med Assoc 1998;212:534-538.
6. Vogel PL, Komtebedde J, Hirsh DC, et al. Wound contamination and antimicrobial susceptibility of bacteria cultured during total ear canal ablation and lateral bulla osteotomy in dogs. J Am Vet Med Assoc 1999;214:1641-1643.
7. Henderson JT, Radasch RM. Total ear canal ablation with lateral bulla osteotomy for the management of end-stage otitis in dogs. Compend Contin Educ Pract Vet 1995;17:157-164.
8. Holt D, Brockman DJ, Sylvestre AM, et al. Lateral exploration of fistulas developing after total ear canal ablations: 10 cases. J Am Anim Hosp Assoc 1996;32:527-530.
9. Matthiesen DT, Scavelli T. Total ear canal ablation and lateral bulla osteotomy in 38 dogs. J Am Anim Hosp Assoc 1990;26: 257-267.
10. Sharp NJH. Chronic otitis externa and media treated by total ear canal ablation and ventral bulla osteotomy in thirteen dogs. Vet Surg 1990;19:162-166.
11. Smeak DS, DeHoff WD. Total ear canal ablation: clinical results in the dog and cat. Vet Surg 1986;15:161-170.
12. Mason LK, Harvey CE, Orshner RJ. Total ear canal ablation combined with lateral bulla osteotomy for end-stage otitis in dogs: results in thirty dogs. Vet Surg 1988;17:263-268.
13. Devitt CM, Seim HB III, Willer R, et al. Passive drainage versus primary closure after total ear canal ablation-lateral bulla osteotomy in dogs: 59 dogs. Vet Surg 1997;26:210-216.
14. Palmeiro BS, Morris DO, Wiemelt SP, et al. Evaluation of outcome of otitis media after lavage of the tympanic bulla and long-term antimicrobial drug treatment in dogs: 44 cases (1998-2002). J Am Vet Med Assoc 2004;225:548-553.
15. Rodloff AC, Hillier SL, Moncla BJ. Peptostreptococcus, propionibacterium, lactobacillus, actinomyces, and other non-spore-forming anaerobic Gram-positive bacteria. In: Balows A, Murray PR, eds. Manual of clinical microbiology. 7th ed. Washington, DC: American Society for Microbiology, 1999;679.
16. Ruoff KL, Whiley RA, Beighton D. Streptococcus. In: Balows A, Murray PR, eds. Manual of clinical microbiology. 7th ed. Washington, DC: American Society for Microbiology, 1999;289-290.
17. Dellinger EP, Gross PA, Barrett TL, et al. Quality standard for antimicrobial prophylaxis in surgical procedures. Clin Infect Dis 1994;18:422-427.
18. Greene CE. Surgical and traumatic wound infections. In: Greene CE, ed. Infectious diseases of the dog and cat. 2nd ed. Philadelphia: WB Saunders Co, 1998;343-347.
19. Page CP, Bohnen JM, Fletcher JR, et al. Antimicrobial prophylaxis for surgical wounds: guidelines for clinical care. Arch Surg 1993;128:79-88.
20. Petersen SW, Rosin E. Cephalothin and cefazolin in vitro antibacterial activity and pharmacokinetics in dogs. Vet Surg 1995;24:347-351.
21. Rosin E, Uphoff TS, Schultz-Darken NJ, et al. Cefazolin antibacterial activity and concentrations in serum and the surgical wound in dogs. Am J Vet Res 1993;54:1317-1321.
22. Whittem TL, Johnson AL, Smith CW1 et al. Effect of perioperative prophylactic antimicrobial treatment in dogs undergoing elective orthopedic surgery. J Am Vet Med Assoc 1999;215:212-216.
23. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals; approved standard. CLASI document M31-A2. 2nd ed. Wayne, Pa: National Committee for Clinical Laboratory Standards, 2002;57.
24. Nishida M, Murakawa T, Kamimura T, et al. Bactericidal activity of cephalosporins in an in vitro model: serum levels. Antimicrob Agents Chemother 1978;14:6-12.
25. Boothe DM. Principles of antimicrobial therapy. In: Boothe DM, ed. Small animal clinical pharmacology and therapeutics. Philadelphia: WB Saunders Co, 2001;137-143.